Bacterial genotoxins: Merging the DNA damage response into infection biology

Biomolecules

Volumn 5, Issue 3, 2015, Pages 1762-1782

  Grasso, Francesca ^a   Frisan, Teresa ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bacterial genotoxins; Cancer; Chronic infection; DNA damage response; Probiotics

Indexed keywords

BACTERIAL TOXIN; COLIBACTIN; UNCLASSIFIED DRUG; MUTAGENIC AGENT;

CARCINOGENESIS; CELL CYCLE ARREST; CELLULAR IMMUNITY; DNA DAMAGE; DNA REPAIR; FLUORESCENCE MICROSCOPY; GENE TRANSLOCATION; HOST PATHOGEN INTERACTION; INFECTION; INTERNALIZATION; INTOXICATION; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BACTERIAL INFECTION; CHEMISTRY; DRUG EFFECTS; GENETICS; HUMAN;

ANIMALS; BACTERIAL INFECTIONS; BACTERIAL TOXINS; CARCINOGENESIS; DNA DAMAGE; HUMANS; MUTAGENS;

EID: 85012044116     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom5031762     Document Type: Review

References (96)

1. Cooke, M.S.; Evans, M.D.; Dizdaroglu, M.; Lunec, J. Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J. 2003, 17, 1195-1214.
2. Elwell, C.A.; Dreyfus, L.A. DNAase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol. Microbiol. 2000, 37, 952-963.
3. Lara-Tejero, M.; Galan, J.E. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000, 290, 354-357.
4. Guerra, L.; Cortes-Bratti, X.; Guidi, R.; Frisan, T. The biology of the cytolethal distending toxins. Toxins 2011, 3, 172-190.
5. Johnson, W.M.; Lior, H. Response of Chinese hamster ovary cells to a cytolethal distending toxin (CDT) of Escherichia coli and possible misinterpretation as heat-labile (LT) enterotoxin. FEMS Microbiol. Lett. 1987, 43, 19-23.
6. Haghjoo, E.; Galan, J.E. Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway. Proc. Natl. Acad. Sci. USA 2004, 101, 4614-4619.
7. Nougayrede, J.P.; Homburg, S.; Taieb, F.; Boury, M.; Brzuszkiewicz, E.; Gottschalk, G.; Buchrieser, C.; Hacker, J.; Dobrindt, U.; Oswald, E. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006, 313, 848-851.
8. Elsen, S.; Collin-Faure, V.; Gidrol, X.; Lemercier, C. The opportunistic pathogen Pseudomonas aeruginosa activates the DNA double-strand break signaling and repair pathway in infected cells. Cell. Mol. Life Sci. 2013, 70, 4385-4397.
9. Nipic, D.; Podlesek, Z.; Budic, M.; Crnigoj, M.; Zgur-Bertok, D. Escherichia coli uropathogenic-specific protein, Usp, is a bacteriocin-like genotoxin. J. Infect. Dis. 2013, 208, 1545-1552.
10. Toller, I.M.; Neelsen, K.J.; Steger, M.; Hartung, M.L.; Hottiger, M.O.; Stucki, M.; Kalali, B.; Gerhard, M.; Sartori, A.A.; Lopes, M.; et al. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc. Natl. Acad. Sci. USA 2011, 108, 14944-14949.
11. Nesic, D.; Hsu, Y.; Stebbins, C.E. Assembly and function of a bacterial genotoxin. Nature 2004, 429, 429-433.
12. Scott, D.A.; Kaper, J.B. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxins. Infect. Immun. 1994, 62, 244-251.
13. Hu, X.; Nesic, D.; Stebbins, C.E. Comparative structure-function analysis of cytolethal distending toxins. Proteins 2006, 62, 421-434.
14. Cortes-Bratti, X.; Frisan, T.; Thelestam, M. The cytolethal distending toxins induce DNA damage and cell cycle arrest. Toxicon 2001, 39, 1729-1736.
15. Jinadasa, R.N.; Bloom, S.E.; Weiss, R.S.; Duhamel, G.E. Cytolethal distending toxin: A conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiology 2011, 157, 1851-1875.
16. Song, J.; Gao, X.; Galan, J.E. Structure and function of the Salmonella typhi chimaeric A2B5 typhoid toxin. Nature 2013, 499, 350-354.
17. Hassane, D.C.; Lee, R.B.; Mendenhall, M.D.; Pickett, C.L. Cytolethal distending toxin demonstrates genotoxic activity in a yeast model. Infect. Immun.2001, 69, 5752-5759.
18. Frisan, T.; Cortes-Bratti, X.; Chaves-Olarte, E.; Stenerlöw, B.; Thelestam, M. The Haemophilus ducreyi cytolethal distending toxin induces DNA double strand breaks and promotes ATM-dependent activation of RhoA. Cell. Microbiol. 2003, 5, 695-707.
19. Elwell, C.; Chao, K.; Patel, K.; Dreyfus, L. Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect. Immun. 2001, 69, 3418-3422.
20. Li, L.; Sharipo, A.; Chaves-Olarte, E.; Masucci, M.G.; Levitsky, V.; Thelestam, M.; Frisan, T. The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells. Cell. Microbiol.2002, 4, 87-99.
21. Asakura, M.; Hinenoya, A.; Alam, M.S.; Shima, K.; Zahid, S.H.; Shi, L.; Sugimoto, N.; Ghosh, A.N.; Ramamurthy, T.; Faruque, S.M.; et al. An inducible lambdoid prophage encoding cytolethal distending toxin (Cdt-I) and a type III effector protein in enteropathogenic Escherichia coli. Proc. Natl. Acad. Sci. USA 2007, 104, 14483-14488.
22. Toth, I.; Nougayrede, J.P.; Dobrindt, U.; Ledger, T.N.; Boury, M.; Morabito, S.; Fujiwara, T.; Sugai, M.; Hacker, J.; Oswald, E. Cytolethal distending toxin type I and type IV genes are framed with lambdoid prophage genes in extraintestinal pathogenic Escherichia coli. Infect. Immun. 2009, 77, 492-500.
23. Janka, A.; Bielaszewska, M.; Dobrindt, U.; Greune, L.; Schmidt, M.A.; Karch, H. Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H- and O157:H7: Characterization and evolutionary considerations. Infect. Immun. 2003, 71, 3634-3638.
24. Peres, S.Y.; Marches, O.; Daigle, F.; Nougayrede, J.P.; Herault, F.; Tasca, C.; de Rycke, J.; Oswald, E. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol. Microbiol. 1997, 24, 1095-1107.
25. Fedor, Y.; Vignard, J.; Nicolau-Travers, M.L.; Boutet-Robinet, E.; Watrin, C.; Salles, B.; Mirey, G. From single-strand breaks to double-strand breaks during S-phase: A new mode of action of the Escherichia coli cytolethal distending toxin. Cell. Microbiol. 2013, 15, 1-15.
26. Sert, V.; Cans, C.; Tasca, C.; Bret-Bennis, L.; Oswald, E.; Ducommun, B.; de Rycke, J. The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaks. Oncogene 1999, 18, 6296-6304.
27. Comayras, C.; Tasca, C.; Peres, S.Y.; Ducommun, B.; Oswald, E.; de Rycke, J. Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing CDC2 protein kinase dephosphorylation and activation. Infect. Immun. 1997, 65, 5088-5095.
28. Dlakic, M. Is CdtB a nuclease or a phosphatase?. Science 2001, doi:10.1126/science.291.5504.547a.
29. Shenker, B.J.; Dlakic, M.; Walker, L.P.; Besack, D.; Jaffe, E.; LaBelle, E.; Boesze-Battaglia, K. A novel mode of action for a microbial-derived immunotoxin: The cytolethal distending toxin subunit B exhibits phosphatidylinositol 3,4,5-triphosphate phosphatase activity. J. Immunol. 2007, 178, 5099-5108.
30. Thiriet, C.; Hayes, J.J. Chromatin in need of a fix: Phosphorylation of H2AX connects chromatin to DNA repair. Mol. Cell 2005, 18, 617-622.
31. DiRienzo, J.M. Uptake and processing of the cytolethal distending toxin by mammalian cells. Toxins 2014, 6, 3098-3116.
32. McSweeney, L.A.; Dreyfus, L.A. Carbohydrate-binding specificity of the Escherichia coli cytolethal distending toxin CDTA-II and CDTC-II subunits. Infect. Immun. 2005, 73, 2051-2060.
33. Cao, L.; Volgina, A.; Huang, C.M.; Korostoff, J.; DiRienzo, J.M. Characterization of point mutations in the cdtA gene of the cytolethal distending toxin of Actinobacillusactino mycetemcomitans. Mol. Microbiol. 2005, 58, 1303-1321.
34. Mise, K.; Akifusa, S.; Watarai, S.; Ansai, T.; Nishihara, T.; Takehara, T. Involvement of ganglioside GM3 in G2/M cell cycle arrest of human monocytic cells induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect. Immun. 2005, 73, 4846-4852.
35. Eshraghi, A.; Maldonado-Arocho, F.J.; Gargi, A.; Cardwell, M.M.; Prouty, M.G.; Blanke, S.R.; Bradley, K.A. Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol. J. Biol. Chem. 2010, 285, 18199-18207.
36. Cortes-Bratti, X.; Chaves-Olarte, E.; Lagergård, T.; Thelestam, M. Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi. Infect. Immun. 2000, 68, 6903-6911.
37. Guerra, L.; Teter, K.; Lilley, B.N.; Stenerlow, B.; Holmes, R.K.; Ploegh, H.L.; Sandvig, K.; Thelestam, M.; Frisan, T. Cellular internalization of cytolethal distending toxin: A new end to a known pathway. Cell Microbiol. 2005, 7, 921-934.
38. Akifusa, S.; Heywood, W.; Nair, S.P.; Stenbeck, G.; Henderson, B. Mechanism of internalization of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Microbiology 2005, 151, 1395-1402.
39. Damek-Poprawa, M.; Jang, J.Y.; Volgina, A.; Korostoff, J.; DiRienzo, J.M. Localization of Aggregatibacter actinomycetemcomitans cytolethal distending toxin subunits during intoxication of live cells. Infect. Immun. 2012, 80, 2761-2770.
40. Gargi, A.; Tamilselvam, B.; Powers, B.; Prouty, M.G.; Lincecum, T.; Eshraghi, A.; Maldonado-Arocho, F.J.; Wilson, B.A.; Bradley, K.A.; Blanke, S.R. Cellular interactions of the cytolethal distending toxins from Escherichia coli and Haemophilus ducreyi. J. Biol. Chem. 2013, 288, 7492-7505.
41. Eshraghi, A.; Dixon, S.D.; Tamilselvam, B.; Kim, E.J.; Gargi, A.; Kulik, J.C.; Damoiseaux, R.; Blanke, S.R.; Bradley, K.A. Cytolethal distending toxins require components of the ER-associated degradation pathway for host cell entry. PLoS Pathog. 2014, 10, e1004295.
42. Guerra, L.; Nemec, K.N.; Massey, S.; Tatulian, S.A.; Thelestam, M.; Frisan, T.; Teter, K. A novel mode of translocation for cytolethal distending toxin. Biochim. Biophys. Acta 2009, 1793, 489-495.
43. Spano, S.; Ugalde, J.E.; Galan, J.E. Delivery of a Salmonella typhi exotoxin from a host intracellular compartment. Cell Host Microbe 2008, 3, 30-38.
44. Guidi, R.; Levi, L.; Rouf, S.F.; Puiac, S.; Rhen, M.; Frisan, T. Salmonella enterica delivers its genotoxin through outer membrane vesicles secreted from infected cells. Cell. Microbiol. 2013, 15, 2034-2050.
45. Cortes-Bratti, X.; Karlsson, C.; Lagergard, T.; Thelestam, M.; Frisan, T. The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J. Biol. Chem. 2001, 276, 5296-5302.
46. Cortes-Bratti, X.; Chaves-Olarte, E.; Lagergård, T.; Thelestam, M. The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J. Clin. Invest. 1999, 103, 107-115.
47. Escalas, N.; Davezac, N.; de Rycke, J.; Baldin, V.; Mazars, R.; Ducommun, B. Study of the cytolethal distending toxin-induced cell cycle arrest in HeLa cells: Involvement of the CDC25 phosphatases. Exp. Cell Res. 2000, 257, 206-212.
48. Hassane, D.C.; Lee, R.B.; Pickett, C.L. Campylobacter jejuni cytolethal distending toxin promotes DNA repair responses in normal human cells. Infect. Immun. 2003, 71, 541-545.
49. Yamamoto, K.; Tominaga, K.; Sukedai, M.; Okinaga, T.; Iwanaga, K.; Nishihara, T.; Fukuda, J. Delivery of cytolethal distending toxin B induces cell cycle arrest and apoptosis in gingival squamous cell carcinoma in vitro. Eur. J. Oral Sci. 2004, 112, 445-451.
50. Sato, T.; Koseki, T.; Yamato, K.; Saiki, K.; Konishi, K.; Yoshikawa, M.; Ishikawa, I.; Nishihara, T. P53-independent expression of p21CIP1/WAF1 in plasmacytic cells during G2 cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect. Immun. 2002, 70, 528-534.
51. Guerra, L.; Albihn, A.; Tronnersjö, S.; Yan, Q.; Guidi, R.; Stenerlöw, B.; Sterzenbach, T.; Josenhans, C.; Fox, J.G.; Schauer, D.B.; et al. Myc is required for activation of the ATM-dependent checkpoints in response to DNA damage. PLoS ONE 2010, 5, e892.
52. Fahrer, J.; Huelsenbeck, J.; Jaurich, H.; Dorsam, B.; Frisan, T.; Eich, M.; Roos, W.P.; Kaina, B.; Fritz, G. Cytolethal distending toxin (CDT) is a radiomimetic agent and induces persistent levels of DNA double-strand breaks in human fibroblasts. DNA Repair 2014, 18, 31-43.
53. Kitagawa, T.; Hoshida, H.; Akada, R. Genome-wide analysis of cellular response to bacterial genotoxin CdtB in yeast. Infect. Immun. 2007, 75, 1393-1402.
54. Smith, J.; Tho, L.M.; Xu, N.; Gillespie, D.A. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res. 2010, 108, 73-112.
55. Blazkova, H.; Krejcikova, K.; Moudry, P.; Frisan, T.; Hodny, Z.; Bartek, J. Bacterial intoxication evokes cellular senescence with persistent DNA damage and cytokine signaling. J. Cell Mol. Med.2010, 14, 357-367.
56. Shenker, B.J.; Hoffmaster, R.H.; Zekavat, A.; Yamaguchi, N.; Lally, E.T.; Demuth, D.R. Induction of apoptosis in human T cells by Actinobacillus actinomycetemcomitans cytolethal distending toxin is a consequence of G2 arrest of the cell cycle. J. Immunol. 2001, 167, 435-441.
57. Ohara, M.; Hayashi, T.; Kusunoki, Y.; Miyauchi, M.; Takata, T.; Sugai, M. Caspase-2 and caspase-7 are involved in cytolethal distending toxin-induced apoptosis in jurkat and MOLT-4 T-cell lines. Infect. Immun. 2004, 72, 871-879.
58. Ohara, M.; Hayashi, T.; Kusunoki, Y.; Nakachi, K.; Fujiwara, T.; Komatsuzawa, H.; Sugai, M. Cytolethal distending toxin induces caspase-dependent and -independent cell death in MOLT-4 cells. Infect. Immun. 2008, 76, 4783-4791.
59. Gelfanova, V.; Hansen, E.J.; Spinola, S.M. Cytolethal distending toxin of Haemophilus ducreyi induces apoptotic death of Jurkat T cells. Infect. Immun. 1999, 67, 6394-6402.
60. Levi, L.; Toyooka, T.; Patarroyo, M.; Frisan, T. Bacterial genotoxins promote inside-out integrin beta1 activation, formation of focal adhesion complexes and cell spreading. PLoS ONE 2015, 10, e0124119.
61. Guerra, L.; Carr, H.S.; Richter-Dahlfors, A.; Masucci, M.G.; Thelestam, M.; Frost, J.A.; Frisan, T. A bacterial cytotoxin identifies the RhoA exchange factor Net1 as a key effector in the response to DNA damage. PLoS ONE 2008, 3, e2254.
62. Hacker, J.; Hentschel, U.; Dobrindt, U. Prokaryotic chromosomes and disease. Science 2003, 301, 790-793.
63. Secher, T.; Samba-Louaka, A.; Oswald, E.; Nougayrede, J.P. Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells. PLoS ONE 2013, 8, e77157.
64. Johnson, J.R.; Johnston, B.; Kuskowski, M.A.; Nougayrede, J.P.; Oswald, E. Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. J. Clin. Microbiol. 2008, 46, 3906-3911.
65. Le Gall, T.; Clermont, O.; Gouriou, S.; Picard, B.; Nassif, X.; Denamur, E.; Tenaillon, O. Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol. Biol. Evol. 2007, 24, 2373-2384.
66. Nowrouzian, F.L.; Oswald, E. Escherichia coli strains with the capacity for long-term persistence in the bowel microbiota carry the potentially genotoxic pks island. Microb. Pathog. 2012, 53, 180-182.
67. Homburg, S.; Oswald, E.; Hacker, J.; Dobrindt, U. Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol. Lett. 2007, 275, 255-262.
68. Dougan, G.; Baker, S. Salmonella enterica serovar typhi and the pathogenesis of typhoid fever. Annu. Rev. Microbiol. 2014, 68, 317-336.
69. Guidi, R.; Guerra, L.; Levi, L.; Stenerlow, B.; Fox, J.G.; Josenhans, C.; Masucci, M.G.; Frisan, T. Chronic exposure to the cytolethal distending toxins of gram-negative bacteria promotes genomic instability and altered DNA damage response. Cell. Microbiol. 2013, 15, 98-113.
70. Cuevas-Ramos, G.; Petit, C.R.; Marcq, I.; Boury, M.; Oswald, E.; Nougayrede, J.P. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl. Acad. Sci. USA 2010, 107, 11537-11542.
71. Buc, E.; Dubois, D.; Sauvanet, P.; Raisch, J.; Delmas, J.; Darfeuille-Michaud, A.; Pezet, D.; Bonnet, R. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS ONE 2013, 8, e56964.
72. Arthur, J.C.; Perez-Chanona, E.; Muhlbauer, M.; Tomkovich, S.; Uronis, J.M.; Fan, T.J.; Campbell, B.J.; Abujamel, T.; Dogan, B.; Rogers, A.B.; et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012, 338, 120-123.
73. Prorok-Hamon, M.; Friswell, M.K.; Alswied, A.; Roberts, C.L.; Song, F.; Flanagan, P.K.; Knight, P.; Codling, C.; Marchesi, J.R.; Winstanley, C.; et al. Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut 2014, 63, 761-770.
74. Arthur, J.C.; Gharaibeh, R.Z.; Muhlbauer, M.; Perez-Chanona, E.; Uronis, J.M.; McCafferty, J.; Fodor, A.A.; Jobin, C. Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer. Nat. Commun. 2014, doi:10.1038/ncomms5724.
75. Cougnoux, A.; Dalmasso, G.; Martinez, R.; Buc, E.; Delmas, J.; Gibold, L.; Sauvanet, P.; Darcha, C.; Dechelotte, P.; Bonnet, M.; et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 2014, 63, 1932-1942.
76. Fox, J.G.; Rogers, A.B.; Whary, M.T.; Ge, Z.; Taylor, N.S.; Xu, S.; Horwitz, B.H.; Erdman, S.E. Gastroenteritis in NF-kappab-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. Jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect. Immun. 2004, 72, 1116-1125.
77. Young, V.B.; Knox, K.A.; Pratt, J.S.; Cortez, J.S.; Mansfield, L.S.; Rogers, A.B.; Fox, J.G.; Schauer, D.B. In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect. Immun. 2004, 72, 2521-2527.
78. Pratt, J.S.; Sachen, K.L.; Wood, H.D.; Eaton, K.A.; Young, V.B. Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect. Immun. 2006, 74, 4496-4504.
79. Shen, Z.; Feng, Y.; Rogers, A.B.; Rickman, B.; Whary, M.T.; Xu, S.; Clapp, K.M.; Boutin, S.R.; Fox, J.G. Cytolethal distending toxin promotes Helicobacter cinaedi-associated typhlocolitis in interleukin-10-deficient mice. Infect. Immun. 2009, 77, 2508-2516.
80. Ge, Z.; Feng, Y.; Whary, M.T.; Nambiar, P.R.; Xu, S.; Ng, V.; Taylor, N.S.; Fox, J.G. Cytolethal distending toxin is essential for helicobacter hepaticus colonization in outbred swiss webster mice. Infect. Immun. 2005, 73, 3559-3567.
81. Ge, Z.; Rogers, A.B.; Feng, Y.; Lee, A.; Xu, S.; Taylor, N.S.; Fox, J.G. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell. Microbiol. 2007, 9, 2070-2080.
82. Graham, D.Y. Helicobacter pylori update: Gastric cancer, reliable therapy, and possible benefits. Gastroenterology 2015, 148, 719-731.
83. Peek, R.M., Jr.; Blaser, M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2002, 2, 28-37.
84. De Bernard, M.; Josenhans, C. Pathogenesis of Helicobacter pylori infection. Helicobacter 2014, 19, 11-18.
85. Yamaoka, Y.; Graham, D.Y. Helicobacter pylori virulence and cancer pathogenesis. Future Oncol. 2014, 10, 1487-1500.
86. Hardbower, D.M.; Peek, R.M., Jr.; Wilson, K.T. At the bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. J. Leukocyte Biol. 2014, 96, 201-212.
87. Kerr, K.G.; Snelling, A.M. Pseudomonas aeruginosa: A formidable and ever-present adversary. J. Hosp. Infect. 2009, 73, 338-344.
88. Wu, M.; Huang, H.; Zhang, W.; Kannan, S.; Weaver, A.; McKibben, M.; Herington, D.; Zeng, H.; Gao, H. Host DNA repair proteins in response to Pseudomonas aeruginosa in lung epithelial cells and in mice. Infect. Immun. 2011, 79, 75-87.
89. Hauser, A.R. The type III secretion system of Pseudomonas aeruginosa: Infection by injection. Nat. Rev. Microbiol. 2009, 7, 654-665.
90. Deng, Q.; Zhang, Y.; Barbieri, J.T. Intracellular trafficking of Pseudomonas ExoS, a type III cytotoxin. Traffic 2007, 8, 1331-1345.
91. Rijavec, M.; Muller-Premru, M.; Zakotnik, B.; Zgur-Bertok, D. Virulence factors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin. J. Med. Microbiol. 2008, 57, 1329-1334.
92. Parret, A.H.; de Mot, R. Escherichia coli's uropathogenic-specific protein: A bacteriocin promoting infectivity? Microbiology 2002, 148, 1604-1606.
93. World Health Organization. IARC working group on the evaluation of carcinogenic risks to humans: Some industrial chemicals. Lyon, 15-22 February 1994. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans/World Health Organization, International Agency for Research on Cancer; World Health Organization: Geneva, Switzerland, 1994; Volume 60, pp. 1-560.
94. Olier, M.; Marcq, I.; Salvador-Cartier, C.; Secher, T.; Dobrindt, U.; Boury, M.; Bacquie, V.; Penary, M.; Gaultier, E.; Nougayrede, J.P.; et al. Genotoxicity of Escherichia coli nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes 2012, 3, 501-509.
95. Guidi, R.; del Bel Belluz, L.; Levi, L.; Fazle Rouf, S.; Candela, M.; Turroni, S.; Nastasi, C.; Consolandi, C.; Peano, C.; Tebaldi, T.; et al. The typhoid toxin enhances host fitness, promotes chronic infection and alteration of the intestinal microbiota. 2015, submitted for publication.
96. Zur Hausen, H. Papillomaviruses and cancer: From basic studies to clinical application. Nat. Rev. Cancer 2002, 2, 342-350.